FR2900575B1 - Gel biocompatible a liberation controlee, son procede de preparation et son utilisation - Google Patents

Gel biocompatible a liberation controlee, son procede de preparation et son utilisation

Info

Publication number
FR2900575B1
FR2900575B1 FR0604068A FR0604068A FR2900575B1 FR 2900575 B1 FR2900575 B1 FR 2900575B1 FR 0604068 A FR0604068 A FR 0604068A FR 0604068 A FR0604068 A FR 0604068A FR 2900575 B1 FR2900575 B1 FR 2900575B1
Authority
FR
France
Prior art keywords
preparation
controlled release
release gel
biocompatible controlled
biocompatible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0604068A
Other languages
English (en)
Other versions
FR2900575A1 (fr
Inventor
Laurence Hermitte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anteis SA
Original Assignee
Anteis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anteis SA filed Critical Anteis SA
Priority to FR0604068A priority Critical patent/FR2900575B1/fr
Priority to PCT/FR2007/000781 priority patent/WO2007128923A2/fr
Publication of FR2900575A1 publication Critical patent/FR2900575A1/fr
Application granted granted Critical
Publication of FR2900575B1 publication Critical patent/FR2900575B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
FR0604068A 2006-05-05 2006-05-05 Gel biocompatible a liberation controlee, son procede de preparation et son utilisation Expired - Fee Related FR2900575B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0604068A FR2900575B1 (fr) 2006-05-05 2006-05-05 Gel biocompatible a liberation controlee, son procede de preparation et son utilisation
PCT/FR2007/000781 WO2007128923A2 (fr) 2006-05-05 2007-05-07 Procede de preparation d'un gel biocompatible a libération contrôlée d'un ou de plusieurs principes actifs peu solubles dans l'eau, gels ainsi obtenus et leur utilisation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0604068A FR2900575B1 (fr) 2006-05-05 2006-05-05 Gel biocompatible a liberation controlee, son procede de preparation et son utilisation

Publications (2)

Publication Number Publication Date
FR2900575A1 FR2900575A1 (fr) 2007-11-09
FR2900575B1 true FR2900575B1 (fr) 2008-10-17

Family

ID=37603377

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0604068A Expired - Fee Related FR2900575B1 (fr) 2006-05-05 2006-05-05 Gel biocompatible a liberation controlee, son procede de preparation et son utilisation

Country Status (2)

Country Link
FR (1) FR2900575B1 (fr)
WO (1) WO2007128923A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
BRPI0819075A2 (pt) 2007-11-16 2014-10-07 Vicept Therapeutics Inc Método para tratar púrpura em um indivíduo e método para diminuir a púrpura em um indivíduo antes de um procedimento cirúrgico
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
FR2927255B1 (fr) * 2008-02-07 2011-08-12 Keysan Consulting Produits injectables biocompatibles a liberation de zinc et/ou de sel de saccharide sous forme de zinc et leurs utilisations.
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
FR2938187B1 (fr) 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
WO2010069519A1 (fr) * 2008-12-18 2010-06-24 Merz Pharma Gmbh & Co. Kgaa Compositions topiques comprenant au moins un ingrédient actif difficilement soluble dans l'eau et des biopolymères, tels que l'acide hyaluronique, présentant une valeur pka située entre 5 et 7
FR2945949B1 (fr) * 2009-05-26 2011-05-13 Anteis Sa Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme.
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
WO2011110894A2 (fr) 2010-03-12 2011-09-15 Allergan Industrie Sas Composition fluide pour l'amélioration d'états cutanés
PL3078388T3 (pl) 2010-03-22 2019-08-30 Allergan, Inc. Usieciowane hydrożele do powiększania tkanek miękkich
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
KR102015676B1 (ko) 2011-06-03 2019-10-21 알러간, 인코포레이티드 항산화제를 포함하는 피부 충전제 조성물
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
WO2016051219A1 (fr) 2014-09-30 2016-04-07 Allergan Industrie, Sas Compositions d'hydrogel stables pourvues d'additifs
WO2016128783A1 (fr) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions et méthodes pour améliorer l'apparence de la peau
FR3036035B1 (fr) 2015-05-11 2018-10-05 Laboratoires Vivacy Compositions comprenant au moins un polyol et au moins un anesthesique
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
FR3058064B1 (fr) 2016-10-28 2020-08-07 Lab Vivacy Composition a base d'acide hyaluronique comprenant de la mepivacaine
US20210402061A1 (en) 2018-05-09 2021-12-30 The Johns Hopkins University Nanofiber-hydrogel composites for cell and tissue delivery
CN112423799A (zh) 2018-05-09 2021-02-26 约翰·霍普金斯大学 用于增强的软组织替代和再生的纳米纤维-水凝胶复合物
FR3111903B1 (fr) 2020-06-24 2022-12-02 Lab Vivacy Procede d’incorporation de composes organiques en solution au sein d’un hydrogel

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570998B2 (en) * 1983-09-07 1988-03-31 Takeda Chemical Industries Ltd. Topical steroid compositions for acne
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
CA2418135C (fr) * 2000-08-03 2011-09-20 Antares Pharma Ipl Ag Composition pour l'administration transdermique et/ou transmuqueuse de composes actifs assurant des niveaux d'efficacite therapeutique adequats
WO2002087563A2 (fr) * 2001-05-01 2002-11-07 Angiotech Pharmaceuticals Inc. Compositions et procedes pour le traitement d'etats inflammatoires par des proteines ou polysaccharides contenant des agents anti-microtubules
EP1465596A1 (fr) * 2002-01-18 2004-10-13 Control Delivery Systems, Inc. Systeme de gel polymere pour administration regulee de medicaments combines
TR200201556A2 (tr) * 2002-06-12 2004-01-21 Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. Kortikosteroid ve nonsteroidal antienflamatuar içeren farmasötik bileşim
HUP0303313A2 (hu) * 2003-10-09 2005-07-28 Richter Gedeon Vegyészeti Gyár Rt. Transzdermális gyógyszerkészítmények
PL1670433T3 (pl) * 2003-10-10 2013-03-29 Ferring Bv Przezskórna formulacja farmaceutyczna do zmniejszania pozostałości na skórze
WO2005074913A2 (fr) * 2004-01-30 2005-08-18 Angiotech International Ag Compositions et procedes pour le traitement de la contracture

Also Published As

Publication number Publication date
FR2900575A1 (fr) 2007-11-09
WO2007128923A2 (fr) 2007-11-15
WO2007128923A3 (fr) 2008-05-02

Similar Documents

Publication Publication Date Title
FR2900575B1 (fr) Gel biocompatible a liberation controlee, son procede de preparation et son utilisation
EP2298375A4 (fr) Dispositif de contrôle d'un coeur artificiel, système de coeur artificiel et procédé de contrôle d'un coeur artificiel
EP1982650A4 (fr) Dispositif d'assistance chirurgicale, procede et programme
IL205593A0 (en) Fecal incontinence device, system and method
EP2209259A4 (fr) Système d'appariement, dispositif de gestion d'appariement, procédé d'appariement et programme
EP2023811A4 (fr) Système chirurgical de contrôle de la trajectoire et procédés associés
EP2043554A4 (fr) Dispositif médical polymère bioabsorbable
EP2195090A4 (fr) Dispositif implantable, système comportant celui-ci, et procédé utilisant celui-ci
EP2353532A4 (fr) Système et procédé de contrôle chirurgical
EP2297689A4 (fr) Dispositif, système et procédé de gestion automatique d instruments financiers
EP1975870A4 (fr) Système de simulation de maquillage, dispositif de simulation de maquillage, procédé de simulation de maquillage et programme de simulation de maquillage
EP2134283A4 (fr) Procédé, système et dispositif d'exérèse de tissu
EP2139432A4 (fr) Systèmes et procédés d'implant déformable
DE602006009682D1 (de) Knochenverankerungsvorrichtung
EP2048639A4 (fr) Système de support de développement de ressources humaines, procédé de support de développement de ressources humaines, système d'application automatique, procédé d'application automatique, et dispositif d'enregistrement
BRPI0814523A2 (pt) Implante biocompatível, método para a formação do implante biocompatível e método de aplicação do mesmo
EP2219206A4 (fr) Dispositif de commande, procédé d'exposition et dispositif d'exposition
IL196422A0 (en) Annuloplasty system and surgical method
IL208415A0 (en) Guided dental implantation system and associated device and method
DE602006010556D1 (de) Knochenverankerungsvorrichtung
DK2767265T3 (da) Justerbart implantatsystem
PL2205185T3 (pl) Urządzenie do wytwarzania zakotwiczenia w tkance ludzkiej lub zwierzęcej
EP2111170A4 (fr) Dispositif et procédés de retenue d'implant
DE602007007758D1 (de) Knochenverankerungsvorrichtung
EP1992216A4 (fr) Procede et dispositif de lutte contre les maladies

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100129